Metsera accepts Pfizer's $10 billion bid in ongoing M&A battle

Metsera has accepted Pfizer's $10 billion acquisition offer. This ends a bidding war with rival Novo Nordisk. Pfizer will pay $86.25 per share. Metsera's board recommended shareholders approve the deal. Pfizer aims to strengthen its position in the growing weight-loss drug market. The merger is expected to close soon after Metsera's shareholder meeting.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/ujIGeUB
via IFTTT